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Objedives. We tested tbe bypotbesis tbat penxat ackieved of 
predkted peak oxygen uptake (predicted %‘o+ax) impnwes tbe 
prognostic accuracy of identitjing bigb risk ambolatary patients 
with congestive beati fuibue conddered for beart tiansplantatiun 
compared with abwlate peak osygea aptake &+ax) in 181 
patients witb iscbemic or dilated cardiomyapatby. 
5ackgrwund. Peak oxygen opt&e doring exe&e has keen 
sbwmtabeawefalpqaastic measwementtarislrstratify 
pat&ntswitbbeartthihwe.Tbepmgiasticvaheafperceat 
pn?dictediro,maxbasnatbeesl~iatbesepatients- 
Melhm!v. We telrosmy studied 181 nmbnlatorg patients 
refed to tbe Satnt Lenis University Heart Failore Uait. Ciiai- 
Cal, hemodynamic (137 patients) aad caromuy aagiagrapbii (145 
pl3tieBtS)datawerCn?CO~dallpstiestsoDdaraent~ 
limited~oaatyexereisa 
patients dii and I8 ~010 listed as Status I priority for beart 
traaspklntation. me actuarial 1. aad zyear sulvival of the 89 
patients wbu tichved SF% predii Qozmax was 74% aad 43%, 
respectively,campuwdwith98%aml!Jtl%intbe92*achiewd 
>50% predktd %pax (p = O.O@l). MaltimiaWe analysis 
sfkcted_c~prPclieted~~nlaxoStbemost~tpredictar 
of~dePth(p=OAYI)aedardisedcrtbor~~slprioritp 
(p = @Am@s). 
Resu&s. During a mean fallow--up period of 12 2 6 moatks, 26 
tIYo&hm Pereeut acbtted of predii h$ax pwides 
importantblf~tbatcanbeusedCri.skstra~amblda- 
tolypatientswitbbeartfaihJrewitbiseeeQtieordilated 
tbat exceeds that pmvided by measuremeat of Togaax done. 
Patientswboacbieve>so%predietPdv~moxbavtancnaUent 
sbort-tffm prqgosis wkea treated medically. ?md beati tratsc- 
plantation can be safely deferA. 
(J Am cdl ckrdid 19!&;27:345-52) 
Congestive hean failure is the leading diagnosis and cause of 
cardio~~at morbidity and mortality reported in recen: years, 
with 1 to 2 milliin Americans affected (1). Despite significant 
advances in medical therapy and the use of angiotensin- 
converting enzyme inhibitor drugs, the survival of patients with 
moderate to severe congestive heart failure remains limited 
(2,3). Heart transplantation enhances survival in seiected 
patients who have severely depressed left ventricular ejection 
fraction, with an 80% to 90% l-year survival (4), significantly 
better than survival of historic controi patients on optimal 
medical therapy (3,!5,6). This has led to increased referrals to 
heart transplantation programs. However, the limited number 
of heart donors has increased the interval preceding transplan- 
tqtion, adversely influencing patient outme (7). Several 
clinical, hemodynamic and exercise criteria have been pm 
posed to identib high risk patients referred for heart trans- 
plantation (8-11). Peakexercise oxygen uptake (ir$max) cl4 
ml/kg per min is one exercise variable reported to predict 
mortality in patients with congestive heart failure with a l-year 
sumiwJ of -7O%, sign&candy Ia than patients with exercise 
capacity >14 ml/kg per min (12). 
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suppbxl in part hy the tichtenstein FoundaM Saiut l&s Mnswri 
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Peak oxygen uptake % inffuenced by age, gender and bo& 
weight (13-18). The use of an exercise variable that adjusts 
for these factors may further improve the prediiive accuracy 
of the iro,max variable in the risk stratification process. 
Dilated cardiomyopathy is reported to have a better outcome 
than ischemic cardiomyopathy (5); however, the prediie 
value of cardiilmonary exercize testing in these two pa- 
tient subsets is not known. Therefore, we tested the hypotheses 
that 1) the use of the percent achieved of predicted vm 
which accounts for age, gender an$ weight. enhances the risk 
stratification of ambulatory patients ev&ated for heart trans- 
plantation cmpared with the use of absolute ,$+max alooe; 
2) the determination of percent predicted Vo,max and 
Vo2max arc predictii of outcome events whether the etiology 
6 is&mic cardiomyopathy or notlischemie&~ cardie 
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Methods 
Between April 1991 and June 1993,181 consecutive ambu- 
latory patients referred to the Heart Failure Program at Saint 
Louis University Health Sciences Center were evaluated (146 
men, 35 women; mean [?SD] age 49 2 IO years, range 21 to 
68 years). The etiology of heart failure was coronary artery 
disease in 94 patients (52%) and dilated cardiomyopathy in 87 
(48%) (idiopathic in 79, valvular in 5, congenital in 3). Previous 
my-dial infarction was reported in 81 patients (45%); 56 
(31%) had history of hypertension; 31 (17%) had history of 
diabetes mellitus; and 105 (58%) had a history of smoking. All 
patients were in New York Heart Association functional 
classes II to III. Rest left ventricular ejection fraction was 
determined from left ventriculography or radionuclide angiog- 
raphy during the initial evs!ueticn. Rest haweline hemody- 
namic dat, were obtained from right heart catheterization 
using Swan-Ganz catheters; cardiac output was determined by 
thermodilution technique. 
Cardiopulmonary exercise testing. Symptom-limited car- 
diopulmonary exercise testing with respiratoty gas exchange 
analysis was performed in 181 patients after written informed 
consent had been obtained. The modified Bruce protocol was 
used in 144 patients (So%), and the modified Asymptomatic 
Cardiac Ischemic Pilot (19) or modified Naughton protocol 
was used in the remaining 37 (20%). Patients with rest or 
crescendo angina pectoris were excluded. All patients with 
ischemic etiology were not candidates for revascularization. 
Standard 1Zlead electrocardiograms were obtained at rest, 
each minute during exercise and for 5 min into the recovery 
phase while blood pressures were measured using a standard 
cutI sphygmomanometer. Leveis of mixed expired oxygen, 
carbon dioxide and ventilation were determined at rest and 
every 30 s using a Medical Graphics Corporation 2001 or 
Cardio, metabolic cart. Anaerobic threshold was defined as 
the Voz at which expired carbon dioxide increased nonlinearly 
relative to oxygen consumption (V-slope) (20). The Vozmax 
was defined as the highest Voz rate observed during exercise. 
Age- and gender-adjusted predicted Voz was determined 
using the treadmill equations of Wasserman et aI. (21) Jones 
et al. (22) and Bruce et al. (17) (see Appendix). The equations 
of Wasserman et al. (21) adjust for age, gender and weight and 
were used in all analyses. 
Fdlow-op. All patients were followed up by the Heart 
Failure Unit at Saint Louis University Health Sciences Center, 
and data Iiom clinic visits, medical records review or telephone 
interview were recorded. Cardiac deaths within 24 h of acute 
symptoms heralded by abrupt loss of consciousness were 
considered sudden, whereas those resulting from progressive 
symptomatic or hemodytiamic deterioration were clas.sihed as 
progressive heart failure. Status 1 patients were defined as 
those ‘patients who required intensive care unit admission and 
prolonged inotropic or mechanical cardiovascular support. 
canliac--relaied events were delined as cardiac death or the 
composite end point of cardiac death or Status 1 transplant 
priority. 
JACC Vol. 27. No. 2 
Fehnmy l9YKM-52 
Statistical analysis. Intergroup digerences among clinical, 
hemodynamic and exercise variables were compared using 
unpaired I tests or chi-square analysis where appropriate. A p 
value <0.05 was considered statistically significant. hi Cox 
proportional hazards model was used to measure the impact of 
clinical history and test results on time to cardiac event. 
Separate analyses were performed for the end point of cardiac 
death and cardiac death or change to Status 1 transplant 
priority. The cardiac event was coded as a binary event, with 
time to follow-up coded in months. Univariate analysis of 
baseline clinical, hemodynamic, angiographic and exercise 
variables was performed for the end points of cardiac death 
and cardiac death or Status 1 transplant priority. Multivariable 
regression analyses were performed on significant univariate 
predictors with p < 0.2 (23). Variables examined were ~50% 
predicted Vo,max, Vozmax 514 ml/kg per min, history of 
myocardial infarction, male gender, functional class, smoking 
history and triple conventional medical therapy. Model- 
overhtting procedures were examined, that is. plots for the 
effect of influential cases and ratio of outcome events to 
number of independent variables (24). The proportional haz- 
ards assumption was satisfied for each regression model. 
Receiver operating characteristic (RGC) curves (True Ep- 
istat, Version 5.0, Epistat Services) were constructed by plot- 
ting true positive rates (sensitivity) against false positive rates 
(1 - specificity) to compare discriminatory accuracy for sur- 
vival and event-free survival for percent predicted Vozmax 
among the equations of Wasserman et al. (?l), Jones et al. (22) 
and Bruce et al. (17) and Vozmax. The ROC curves were 
compared using the z statistic (25). The area under the ROC 
curve is a measure of the discriminatory accuracy of a variable 
in I- “?ing outcome. A test with a high sensitivity and 
specificity will produce a curve shifted up and to the left 
compared to a test providing random estimates that will 
produce a 45” line. The area under the curve can range from I 
to 0, with 1 being perfect discrimination, 0.5 having no more 
discrimination than random chance and 0 being perfect incor- 
rect discrimination. 
Results 
The clinical characteristin and hemodynamic and exercise 
data of the study patients are presented in Table 1. The mean 
percent predicted Vozmax for all patients was 54 -C 19%. The 
mean Vc,max was 16.3 -C 5.9 ml/kg per min. Anaerobic 
threshold could not be detemllned in 16 patients; peak respi- 
ratory exchange ratio (r) was >l.O in these patients. There 
were no complications as a result of the exercise test proce- 
dure. 
After 12 + 6 months of follow-up, 44 patients (24%) 
experienced an event (cardiac death, Statss I). Of 26 patients 
wt., died, 12 had a sudden cardiac death, and 14 died of 
progressive heart railure. Twenty deaths occurred in patients 
with coronary artery disease. Thiifrve patients received a 
heart transplant. Eighteen patients were listed as Status 1, and 
17 were listed as Status 2 priority for heart transplantation. ‘Ihe 
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Table 1. Clinical Characteristics and Hemodynamic and Exercise Data of 181 Patient\ With 
Congestive Heart Failure and Coronary Artey Dtsease TV Dildted Ctrdiomyopathy 
___- 
Etiol~ 
Ail f’t~ C.43 DCM P 
(n = 181) (n = 9-t) (n = 87) Value 
Age b) 49 f IO 53 f 8 tJr 11 <OOi@ 
Gender 
Male I46 (RI) n5 (W) 61 (70) Il.(l(l(li 
Female 35 (19) Y(W) 26 r301 
NYHA fwetioual class 
II 60 (33) 25 127) 35 NO) ss 
111 El(67) 69 (73) 52 (601 NS 
LVEF (%) WC9 23rR 23 + NJ NS 
pw (mm W 22 -: Y 22 z 9 21 r9 s5 
Cl (IiteN’mm per m’) 2.4 _i O.h 2.5 z 0.6 2.2 ? 0.h rf 0: 
%PPVo, 54 2 1Y 47z 15 fti I 20 ,il IWI 
PVoz (ml&g per mitt) 16 t 5 5.Y 14.4 z 4.5 ihlr6.c i’ i Mli 
CO, production (liter$min) 1.6 + 0.7 1.4 = 4.5 1 7 f 0.8 O.lXY~ 
Ventilation (liters/mitt) 64 t 20 622 17 tdJ f 2 YS 
Respiratory exchange ratio 1.15 f 0.12 1.162 0.13 1.14 rll.11 SS 
Follw-up (mo) 12 2 b 12 z 6 11=: VI 
Death M(14) 20 (21) 6(i) WC6 
Death or Status 1 M (24) 28 (30) 16(1P) us 
~prcsen~aremeanvaluerSDornumber(c/r)ofpailents(Pts).CAD=awo~~yarte~~.~F=~~r 
bean failure; CI = eardiae index; CCte = carbm dii DCM = dilated car- LVEF = kft\emrmdar qexzkn 
fractia; NYHA = New York Heart Association: PCWP = puhnorwy capillary zedge prewte: “U’Piio, = percent z&e& 
Or predicted peak oxygen uptake (Wascrntae et at. [?I1 fcrmula); PVo, = peak oxvgn uptake. 
clinical and hemodynamic characteristics between survivors 
and nonsurvivors are summarized in Table 2. 
Comparison of cardiopulmonary exercise variables between 
nonsurvivors and survivors is displayed in Table 3. Nonsurvi- 
Table 2. Clinical and Hemodynamic Characteristics of Nonsurviving 
and Surviving Patients With Congestive ;jeart Failure 
NOllSUlViVOIS sution P 
(it = 26) (n = 155) Value 
Age W 
Male 
LVEF (%) (145 pts) 
Pcwp (mm Hg) 
m+P (mm Hg) 
RA (mm Hid 
NYHA timctiorlal class 
II 
II1 
CAD 
MI 
smdring 
Rae (white) 
ACE inhibitor 
Digitalis 
Diuretic 
3(12) 
23 (88) 
24 m 
19 (73) 
21(81) 
21(81) 
25 (W 
23 w 
24 (92) 
48-t 10 
121(78) 
2329 
21 r8 
lM+ 10 
926 
57(3?1 
% (631 
74 w 
62 :401 
83 (54) 
137 (88) 
13- (88) 
117(75) 
126(81) 
NS 
0.03 
NS 
0.01 
NS 
NS 
0.04 
0.04 
O.lM 
0 ‘M 
0.01 
NS 
NS 
NS 
3s 
vors achieved a lovver percent predicted i’o,max (38 I ltl’i vs. 
57 2 180/c, p < OMJOl) and ke; ~'O~IEW (I? + 4 vs. 17 t 6. 
p < O.oOOl) than survivors. 
Mnl~ models. Multivariable models to predict car- 
diac death and cardiac death or Status 1 w-ere run to examine 
important baseline and exercise variables (Table 4). The only 
independent predictor of cardiac death was 9+tl% predicted 
irormax (p = 0.007); ~50% predicted Vo,max (p = 0.0005) 
and functional class (p = 0.04) were indeperdent predictors of 
cardiac events. 
Table 3. Comparison of Cardiitnon~ Exercise Testing 
Variables in Notutttion and Survivors 
CTPPVO, 38 t to .c7= IS COW31 
PVol (mlkg per mm) 12 I4 17~6 e:u.wu 
AT (ml& per mih) 9.4 z 2.4 12-i r 3.7 0.m 
Exerc%e duration tmio)’ 4.6 z ?.I 63 -2.3 I! ml 
rso% PPVO, 14192) 65 (42) 4lWI 
PVo2 5 14 mtkg per mio 33177) .W til) ~3%XJl 
co, gschclm @teSti) 1.2 zt1-c Lb f 07 (l.uJ3 
Ventilation (litersmis) 62r 18 MZ3) NS 
Respiratory eachmge ratio I.19 2 0.1 I.15 f 0.1 NS 
tPMHR 80=9 85 f Ii NS 
Peak q-xmlic t3P (mm Hg) 117?2@ 137 2 31 lMO3 
‘144 pa-iem psfomrd mod&d 5rw proud. Data presented are mean 
rSDornunber~‘i)ofparjeaU.~T=~:rarobntbr~:BP;~wd 
pewr~ Q%DiR = percent of pm&ted m&tal heart rate: ether abhrew 
t&tSaShtThle I. 
Trip& therapy’ 21(81) %W 0.03 
*Augiotemin-eouvening enzyme (ACE) iuhihitor. ditalii attd diuretie drug 
eomhhtedmedieal:herapy.Datapresentedaremeanvahte ?SDoratmkr(S) 
of p&mu (;:I,!. MAP = mean arterial pressure; MI = myucardial ir&rction. 
RA = rigbt mid p-emre; other &reviations as in Table 1. 
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Table A Moltivariable Models for Death and Death or Status 1 
A-ding to Known Prognostic High Risk Variables 
- 
step Beta P 
NO. Coefficient SE VdUC 
Death 
$0 %PPVo, 1 2.16 o.n 0.007 
Wo, 514 ml/kg per min 2 0.85 0.5 0.09 
Male gmder 3 0.66 0.52 0.2 
MI 4 0.19 0.23 (1.43 
NYHA liJnctional elm 5 0.14 0.36 0.68 
550 %PPi$ 1 1.62 0.46 O.lmE 
NYHA fllnctional elm 2 1.12 0.55 3.04 
Male gender 3 0.76 0.61 0.22 
Smoking histoy 4 0.33 0.35 0.34 
Tnde therapy 5 0.19 II.38 0.61 
MI 6 011 Il.33 0.73 
PVO, 514 ml/kg per min 7 0.12 0.38 0.76 
Abbreviations as i? Tables 1 and 2. 
Survival was assessed using cSO% and >50% predicted 
iro,max as a cut point. The 80 patie,lts who achieved ~50% 
predicted ir,,max had a significantly worse survival than the 
92 patients who achieved :50% predicted voiro,max (p = 0.001) 
(Fig. 1). When survival of the 92 heart failure patients who 
achieved HO 7c predicted ?3,max was compared with that of 
35 patients who underwent heart transplantation, the 2-year 
survival rates were 90% and 8Y%, respectively (p = h’s). 
Similar survival rates were observed when patients were drat- 
itied using iro,max 514 (n =- 70) and >14ml/kg per min (n = 
111) (p = 0.001). Separate analyses for the combined end point 
of cardiac death or Status 1 revealed a greater event rate in 
Fii 1. Survival curves comparing patients achieving ;.iC!5 (pre- 
served exercise capacity) with those achieving ~5OYG (reduced exercise 
capacity) predicted peak oxygen uptake (PPVW). Numbers in psren- 
theses = number of patients at risk. 
*od 
75 
z 
p-c 0.001 
* >w%PPvo2 
- ao%PP302 
p< 0.0001 
--o- >5o%PPjl02 
----t SQ%PP+o2 
0 1 
0 6 12 16 24 
Duration of Follow-up (Months) 
Figure 2. Event-free survival (death or Status 1) curves comparing 
patients achieving >509 (preserved exercise capacity) with those 
achieving ~5076 (reduced exercise capacity) predicted peak oxygen 
uptake (PP’&)2). Numbers in psrestbeses = number of patients at 
risk. 
patients unable to achieve SO% predicted *o,max (p < 
0.0001) (Fig. 2). The results were similar using a cut point of 
514 and >14 ml/kg per min (p < 0.0001). Although both 
percent predicted \io,max and iro,max were significant pre- 
dictors of cardiac events, the percent predicted iro,max pre- 
dicted 10 more events (4 cardiac death, 6 Status 1) than 
Vo,max (n = 38 vs. n = 28). 
Diagnostic accursey of csrdiipulmonary exercise testing. 
‘The discriminatory accuracy using the cut point of 50% 
predicted ir,,max for the equation of Wasserman et al. (21) 
was compared with that obtained using the Jones (22) and 
Bruce (17) equations (Table 5). The Wasserman (21) equation 
had slightly greater diagnostic accuracy and a greater area 
under the ROC curve than both other equations. The differ- 
ence was not statistically significant. The equation of Wasser- 
Table 5. Area Under Receiver Operating Characteristic Curve for 
Predicted Maximal Oxygen Uptake Equations for Death and Death 
or Status 1 
ROC p value 
Equation Area 2 score SE (ys. 015 ROC area) 
al 
0 6 12 18 24 
Duration of Follow-up (Months) 
Death 
Wawrman et al. (21) 0.82 8.58 o.lM 
Bruce et al. (17) Il.79 6.16 0.05 
Jones et al. (22) 0.77 555 0.05 
Death or Status 1 
Wasmnan et al. (21) 0.78 7.60 0.04 
Bruce n al. (17) 0.75 6.26 0.04 
Jones et al. (22) 0.75 6.21 0.04 
ROC = receiver operating draraaeristic auve. 
<O.ool 
<O.CNU 
<O.Ml 
<o.an 
<o.onr 
<O.ool 
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Table 6. Sensitivity and Specificity for Percent Prediied Maximal 
Oxwen Uotake Cut Points in Fxmations* for Death or Status 1 
-1‘ . 
30% 40% 507G t&l% 
Sensitivity II 55 116 93 
Specificity 95 84 63 41 
‘War.wm?30 et al. (21). 
man et al. (21) was used in all subseauent analvses. The 
sensitivity aid ‘specificity of various percentage -predicted 
iro2max cut points for the combined end points of cardiac 
death or Status 1 are illustrated in Table 6. The optimal cut 
point for percent predicted \io,max was 50%. The sensitivity 
to predict cardiac death for ~50% predicted \jnLznax old 
vo2max cl4 was 92% and 77%, respectively, and specificity 
was 58% and 68%. Similarly, the sensitivity for CiO% pre- 
dicted vo,max was higher than iro2max 514 when the com- 
bined end points of cardiac death or Status 1 were analyzed 
(86% vs. 68%). with similar specificity (63% vs. 6%). 
The overall discriminatory accuracy using ROC analysis for 
percent predicted vo2max (0.78) was significantly greater than 
that for vo,max (0.72) (p = 0.036) for cardiac-related events 
(Fig. 3). The difference was not significant for cardiac death 
(0.82 vs. 0.78, p = 0.15). 
AnaIysIs aecordIng to heart faRare typo Separate inivari- 
ate and Cox multivariable analyses of the 94 patients with 
coronary artery disease and 87 patients with dilated cardio- 
myopathy were performed to examine the impact of etiology 
on outcome. In the 94 patients with coronary artery disease 
etiology, ~50% predicted iro,max, \io,max 514 and triple 
conventional medii therapy were significant univariate pre- 
dictors (p < 0.2) (23) of both cardiac death and cardiac death 
or Status 1. When these variables were entered into 3 multi- 
variable model, 550% predicted iro,max was the only remain- 
ing independent predic$or of cardiac death (p = 0.04) or any 
cardiac-related event (p = 0.02). The 20 patients with coronary 
artery disease who died had 3 significantly lower percent 
F&we 3. Receiver-operating characteristic (ROC) curves for l-year 
event-free survival (death or Status 1). The area under the ROC curve 
for percent predicted peak oxygen uptake (%PP\jOt) indica&s signif- 
icantly improved @criminatory accuracy compared with that for peak 
oxygen uptake (PV02) (0.78 vs. 0.72, p = 0.036). 
1 
- I 
0.0 
a- 0.0 
g 
H 0.4 
~ 
/- 
i P-O.@= 
LJ 
-tklvioa j 
-F+oz I 0.2 
.A, 
“1 
0 0:2 0:4 as Oi ; 
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predicted ir,,rnax (38 t 10% vs. 50 -t 15%, p = 0.001) and 
lower iro,max (12 t 4.3 mI/kg per,min vs. 15 L 4.4 ml& per 
min, p = 0.006) than the 74 survivors. 
When the 87 patients with dilated cardiomyopathy etiology 
were examined, 150% predicted iro,max, iro2max cl4 and 
functional class were the only significant univariate predictors 
for the combined end point of cardiac death or Status 1. When 
these variables were entered into a multivariable model, 150% 
predicted ird,max was the only remaining independent pre- 
dictor (p = 0.02). The six patients with dilated cardiomyopathy 
who died had a significantly lower percent predicted iro,max 
(36 -C 9% vs. 63 ?z 20%, p = 0.002) and lower iro,max (12.5 + 
1.9 ml/kg per min vs. 18.9 _f 65 mI/kg per min, p = 0.02) than 
survivors. The differences were simi!ar when the combined end 
point of cardiac death or Status 1 priority was analpd. 
Discussion 
The incidence of congestive heart failure is increasing 
despite an observed decline in coronary artery disease mortal- 
ity (1,26). The median survival of patients with severe conges- 
tive heart failLie is 2 to 3 years (27). Risk stratification of 
ambulatory congestive heart failure patients is primarily based 
on subjective me%ures such as clinical and hmctional ilssess- 
ment and rest hemodynamic data. The use of exercise toIer- 
ante evaluation in these patients provides an ob+?ive method 
to identiry patients at higher risk of cardii death and provides 
long-term prognostic information. The data are useful in 
selecting patients who could potentially benefit from heart 
transplantation (12). 
Our data show that the use of cardiopuhnomuy exercise 
testing and determination of the percent achieved of pred&ed 
\iozmax is a bigbiy accurate predictor both in identifying 
patients at risk for future cardiac events (cardiac death or 
Status 1) and in identifying Iow risk patients who can be 
followed up clinically and maintained on medicaI thew with 
relatively low mortality or morbidity. Our data confirm eartier 
results on the value of i$max as 3 useful predktor of 
mortality and morbiity (5,8,12). However, percent predicted 
i$max and the cut point 550% pmdicted iro,max are more 
sensitive in detecting events then the use of absolute V~rnaq 
which do& not adjust for age, weight or gender. 
previoasshdios CiAnetaL(28)reportedintheDepaC 
ment of Veterans Affairs &operative Vasodiiator-Heart Fail- 
ure Trials (V-Hem I,II) tbat ejectioa fix&on, cardiotboracic 
ratio aud iro,max were independeot pxdictors of all-cause 
mortality. When Vqnax was 514.5 m&g per min, sun+val 
rates were signilicantly k tban in patients with Vo$nax 
>14.5 ml/kg per min. In the V-HeFT I trial, irc+max only 
added signiticant independent prognostic informatxon in the 
p3tientsubsetkitb3me&nejectbnfmctim>028.Inbot.h 
V-Hem 1 (n = 642) and V-Hem II trials (n = %04), the wmt 
smiv3lrateswereobsefvedinmcntithakftven~ 
ejection fraction 10.28 a+ ‘&rnax 914.5 n&kg per min. 
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death after 11 2 9 months in 122 patients referred for cardiac 
transplantation evaluation. Patients with Vo,max <14 mI/kg 
per r&n who were accepted for transplantation had a l-year 
survival of 70% compared to I- and 2-year survival of 94% and 
&I% in patients exceeding 14 ml/kg per min. The results are 
comparable to our observations using percent predicted 
Vqmax with patients achieving ~50% predicted Vormax 
having a l- and 2-year survival of 74% and 43% versus l- and 
2-year survival of 98% and 90% in patients who achieved 
>50% predicted Vormax. The latter group had survival at 1 
year si$lar to 35 patients who underwent heart transpls*?‘a- 
tion. Likoff et al. (5) studied 201 patients with congestive heart 
failure with a mean follow-up of 10.8 t 9 months and reported 
that patients with Vqmax 513 ml/kg peg min had a substan- 
tially higher m,rtality rate than the 15% 1-year mortality in 
patients who exceeded 13 ml/kg per min. 
Parameshwar et al. (8) reported on 127 patients with 
chronic heart failure who underwent cardiopulmonary exercise 
testing with 14.6 months of follow-up; total and event-free 
survival in patients with Vormax ~13.7 ml/kg per min was 
-70% and 45% compared with -85% and 60% in patients 
with Voamax >13.7 ml/kg per min. 
!klection ati value of pennt achieved of predicted 
v%max. We selected 50% to enhance the sensitivity of pre- 
dicting occurrence of cardiac events, a desirable feature of any 
screening test. The percent achieved of predicted Vo,max was 
the strongest predictor for cardiac death and cardiac death or 
Status 1 listing by multivariable analysis. 
The data indicate that correction for factors that inherently 
affect Vormax duting exercise using the equation of Wasser- 
man et al. (2i), \-.1&h accounts for age, gender and body 
weight, enhances t ;e predictive accuracy of cardiopulmonary 
exercise testing in risk stratification of ambulatory patients 
with congestive heart failure, whether the etiology is secondary 
to ischemic heart disease or dilated cardiomyopathy. Similar 
results can be achieved with other formulas that adjust for age 
and gender onIy (17,22). Although we examined only three 
formulas to derive percent predicted Vo,max in this study, 
other equations can also be used to derive percent predicted 
Vqmax (29,30). 
fhmparis~n with other prediirs. The predictive accu- 
racy of clinical and hemodynamic variables was tested for their 
prognostic value in detecting future cardiac events. Functional 
CIRSS was the only significant clinical variable in multivariable 
analysis (Table 4). The clinical findings are at variance with 
other studiis that report right atrial pressure >12 mm Hg (31) 
plasma sodium Cl38 mmol/liter (8) and left ventricular ejec- 
tion fraction <17% (8) as significant multivariable”predictors 
of death. Griffin et al. (32) reported on 49 patients with chronic 
congestive heart failure who underwent rest and exercise 
hemodynamic evaluation. The l-year mortality was 33%. Rest’ 
pulmonary artery wedge pressure and peak exercise stroke 
work index were the only independent mortality predictors 
Differences in exercise duration or Vormax achieved between 
SmVi#rS and nonsurvivors were not sign&ant. The number of 
ptiettt~ in thii series was small, and a type II error cannot be 
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excluded. Pulmonary capillary wedge pressure was a univariate 
predictor in our series but was not selected after exercise, 
results were entered into the model. The type of exercise 
performed (bicycle exercise) and the inclusion of patients with 
functional ,class IV heart failure in the study by Griffin et al. 
(32) (25% of participants) may also explain the differences 
observed. 
In patients with congestive heart failure, coronary artery 
disease adversely affects prognosis (33). Thus, exercise out- 
come predictors such as percent predicted Vo,max or Voo,max 
may potentially be influenced by the type of patients with 
congestive heart failure selected for study. In the SOLVD trial 
(34) Vozmax did not differ between subjcsts with ischemic 
(n = 139) and nonischemic heart disease (n = 25); Vo,max did 
correlate significantly with age and gender. In our series of 94 
patients with ischemic cardiomyopathy and 87 patients with 
nonischemic dilated cardiomyopathy, percent predicted 
Vo,max was significantly different between the two types of 
cardiomyopathy and was a useful variable in predicting out 
come in both groups. The magnitude of prognostic separation 
was greater in the ischemic cardiomyopathy group. 
Study limitations. The study cohort represents a large 
group of patients with congestive heart failure. Approximately 
half of the study cohort had ischemic cardiomyopathy, and the 
remainder had nonischemic dilated cardiomyopathy. The in- 
clusion of the two different types of cardiomyopathy could have 
influenced the results. However, both patient groups share 
many similarities in their clinical, hemodynamic and therapeu- 
tic characteristics at the time of exercise testing, and we have 
shown the prognostic utility of cardiopulmonary exercise test- 
ing in both groups. The small number of cardiac deaths (n = 6; 
7%) in the 87 patients with dilated cardiomyopathy precludes 
an in-depth prognostic assessment of this subgroup. Additional 
prospective studies with a larger series of patients with dilated 
cardiomyopathy are needed to substantiate the prognostic 
value of percent predicted Vo,max in this cohort. 
The use of previously published data regarding age-, 
gender- and weight-adjusted Vo2max as a control value to 
derive the percent predicted oxygen uptake rate may not be the 
optimal method to determine the degree of exercise capacity 
impairment. However, the formulas are derived from large 
cross-sectional studies and represent a normal population, 
which we believe justifies the use of these data to represent a 
hypothetica! control group. We tested our hypotheses for 
percent predicted Vo,max using other published predicted 
Vo,max formulas (17,22) and found that the results were not 
significantly influenced by Choice of reference group. 
We did not study a large group of women (n = 35) in our 
study, and the small number of events observed (n = 3) 
precludes firm conclusions regarding impact of gender on 
survival. 
A potential limitation is the use of different exercise 
protocols in this study. However, analysis of the 144 patients 
who performed cardiopidmonary testing using the modified 
Bruce protocol gave similar results to patients who performed 
a non-Bruce protocol. The protocols used were compared in 
JACC Vol. 27, No. 2 
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our laburatory in normal subjects and in patients with coronary 
artery disease (19). Peak oxygen uptake rate values were 
similar regardless of exercise protocol used. 
Chid implications. The present report extends previous 
observations of the significant predictive value of cardiopul- 
monary exercise testing in the risk stratification of patients with 
severe congestive heart failure. The use of 30% predicted 
iro,max provides prognostic information additional to the 
absolute iro,max and can eliminate the potential influence of 
factors such as age, gender, and weight on the predictive 
accuracy of the test. Our data demonstrate that patients who 
receive optimal medical therapy and have preserved exercise 
capacity can continue to be followed up clinically and undergo 
serial cardiopulmonary exercise testing to determine the opti- 
mal time and potentially prevent adverse outcomes, although 
this hypothesis needs to be tested prospectively. This approach 
can assist in decreasing the waiting time for patients awaiting 
heart transplantation by optimizing the selection process. 
We thank Frances Hammack for secretarial rupporr; Ruth Nelson-N&at, Pat 
Armstrong, Mary Glare Defier, RN, Elizabeth MerWe. RN and Eileen Wetzel 
for technical support. 
Appendix 
Determination of Age- and Gender-Adjusted 
Predicted Maximal Oqgen Consumption 
E4ptlons of Wasseman et al. (21). To relate normal weight to 
height the following equation was utilized: W = 0.79H - 60.7 for men 
and W = 0.79H - 68.2 for women, where W = weight in kilograms, 
and H = height in centimtien (17). If a patient’s actual weight was at 
or below normal, the weight and age were used to predict maximal 
oxygen uptake (%‘oimax) (ml/min): 
Men: W X (56.36 - 0.413 X Age); 
Women: W X (3L.37 - 0.413 X Age). 
If a patient was overweight. his or her “normalized” weight was 
integrated to predict vo,max (mlimin): 
Men: (0.79 x H - 60.7) Y (56.36 - 0.413 X Age): 
Women: (0.79 x H’- 68.21 x (44.37 - 0.413 X Age). 
Egoations of Jones et al. (22). Gender and age were used to predict 
voZmax (litersimin): 
Men: 4.2 - 0.032 X Age: 
Women: 2.6 - 0.014 X Age. 
t%qnab of &wee et al (17). Gender and age were used to predict 
hgnax (m&g per min): 
sederluy men: 518 - 0.445 x Age: 
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